Correction to NPS Hormone Drug Article on Friday
24 Enero 2015 - 4:40PM
Noticias Dow Jones
NPS announced in December that the European Medicines Agency
validated its marketing authorization application and started its
review of the drug. "NPS Hormone Drug Gets FDA Approval," at 7:54
p.m. EST on Friday, misstated the drug got EMA approval in the
ninth paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Nps (NASDAQ:NPSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Nps (NASDAQ:NPSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
Más de NPS Pharmaceuticals Inc. Artículos de Noticias